OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Metabolomics
(1)
Repository
MetaboLights
(1)
Technology Type
Mass spectrometry
(1)
Instrument Platform
Liquid Chromatography MS – NEG
(1)
Liquid Chromatography MS – POS
(1)
Publication Date
2023
(1)
CHEBI ID
CHEBI:131690
(1)
CHEBI:133142
(1)
CHEBI:133145
(1)
CHEBI:133148
(1)
CHEBI:134016
(1)
CHEBI:139328
(1)
CHEBI:140131
(1)
CHEBI:140773
(1)
CHEBI:153787
(1)
CHEBI:15745
(1)
CHEBI:15793
(1)
CHEBI:16566
(1)
CHEBI:16765
(1)
CHEBI:16828
(1)
CHEBI:169042
(1)
CHEBI:169088
(1)
CHEBI:169154
(1)
CHEBI:169502
(1)
CHEBI:17027
(1)
CHEBI:170607
(1)
CHEBI:172412
(1)
CHEBI:172645
(1)
CHEBI:173335
(1)
CHEBI:173475
(1)
CHEBI:173817
(1)
CHEBI:174273
(1)
CHEBI:174697
(1)
CHEBI:178341
(1)
CHEBI:17889
(1)
CHEBI:183524
(1)
Metabolite Name
(Z)-tamarindienal
(1)
1-nitroheptane
(1)
2-amino-3-methoxy-benzoic acid
(1)
2-aminomuconic acid semialdehyde
(1)
3-hydroxyanthranilic acid
(1)
3-hydroxynevirapine
(1)
3-methoxyanthranilate
(1)
3b-hydroxy-6b-(3-chloro-2-hydroxy-2-methylbutanoyloxy)-7(11)-eremophilen-12,8b-olide
(1)
3′-sialyllactose
(1)
4-hydroxybenzylamine
(1)
5-methylthioribose
(1)
Allysine
(1)
Anabsin
(1)
CE (18:3(9Z,12Z,15Z))
(1)
Chloropanaxydiol
(1)
Cis-5-tetradecenoylcarnitine
(1)
Cohibin D
(1)
Daphniphylline
(1)
Dodecanoylcarnitine
(1)
Elaidic carnitine
(1)
Harderoporphyrinogen
(1)
Hexacosanal
(1)
Indoleacrylic acid
(1)
L-tryptophan
(1)
N1,N12-diacetylspermine
(1)
N1,N8-diacetylspermidine
(1)
PE (20:4(5Z,8Z,11Z,14Z)/P-18:0)
(1)
PE (P-18:0/0:0)
(1)
PI (18:0/0:0)
(1)
PI (20:4(5Z,8Z,11Z,14Z)/0:0)
(1)
Release Date
2019
(3)
2017
(3)
2023
(2)
2020
(2)
2016
(2)
2014
(2)
2024
(1)
2022
(1)
2018
(1)
2010
(1)
2009
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae.
Not available
S-EPMC7526826
|
biostudies-literature
Cite
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
Not available
S-EPMC2715599
|
biostudies-literature
Cite
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients.
Not available
S-EPMC9394369
|
biostudies-literature
Cite
Ampicillin/sulbactam versus cefuroxime as antimicrobial prophylaxis for cesarean delivery: a randomized study.
Not available
S-EPMC3009979
|
biostudies-literature
Cite
Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study.
Not available
S-EPMC11359551
|
biostudies-literature
Cite
Outbreak of KPC-2-producing
Klebsiella pneumoniae
endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019.
Not available
S-EPMC6988274
|
biostudies-literature
Cite
Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.
Not available
S-EPMC7264071
|
biostudies-literature
Cite
Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae.
Not available
S-EPMC5885010
|
biostudies-literature
Cite
Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece.
Not available
S-EPMC4148920
|
biostudies-literature
Cite
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).
Not available
S-EPMC7437259
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
